Portland, OR -- (ReleaseWire) -- 06/03/2014 -- China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB 1550 billion (about US$246 billion). China is expected to become the second largest drug market in the world by 2015 with a growth rate over 25 percent per annum in next three years. As China joins the World Trade Organization (WTO) and integrates more completely into the global economy, it will further open the door to a lucrative drug market for overseas pharmaceutical companies, which attracts more and more overseas pharmaceutical manufacturers and producers to enter such drug market and seize a larger part of such drug market. However, the Chinese social environment for the protection of intellectual property right is complex. The locally produced generics and copy products dominate the Chinese drug market. It is estimated that about 97 percent of the drugs produced by local companies are generics or counterfeits.
Facing such complex social environment and market, most overseas and multinational pharmaceutical companies fear that their imported drugs and pharmaceuticals produced in China will be imitated or copied, in turn, their intellectual property will be infringed and benefit will be violated. What reason incurred such fear of overseas and multinational pharmaceutical companies? Why did Eli Lilly & Company fail in its litigation of patent infringement dispute case inChina? Why can Pfizer win in an administrative proceeding against the Patent Reexamination Board of the China State Intellectual Property Office (SIPO) for its Viagra patent? Lack of knowledge of the Chinese intellectual property right system and legislation institution, the cultural difference between China and Western countries as well as the language barriers incurred such result.
To Get Full Access of Report visit: http://www.bigmarketresearch.com/China-pharmaceutical-patent-protection-market
China’s Guidebook for Pharmaceutical Patent Protection is an essential resource for overseas and multinational pharmaceutical companies to achieve a successful patent protection for their intellectual property in China. This guidebook, targeting overseas and multinational pharmaceutical companies and combining case studies of patent infringement dispute in China from them, will provide a comprehensive and thorough knowledge of the Chinese patent system and legislation institution to guide overseas and multinational pharmaceutical companies step by step to achieve a successful patent protection for their intellectual property in China, which is beginning from the organization structure and the responsibility of Chinese patent authorities, the application for patent, the examination and approval of application for patent, the protection of patent right, to design for compositions of optimized patent protection strategies. Its audiences are the executives from overseas and multinational pharmaceutical companies who have the preliminary knowledge of patent. It is also a textbook for the readers studying in the patent protection for intellectual property rights relating to pharmaceuticals. After having skimmed through this guidebook, audiences and readers can not only be clearly aware of the Chinese patent system and legislation institution, but also design an optimized patent protection strategy for themselves to acquire an adequate protection for their patent right in China.
China’s Guidebook for Pharmaceutical Patent Protection provides a comprehensive and thorough knowledge of the Chinese patent system relating to pharmaceuticals, the detailed administrative, civil and criminal judicial pathways for protections of patent right, and the design for composition of optimized protection strategies.
The organization structure of patent authorities and judicial system;
A comprehensive and thorough knowledge of the Chinese patent system and the relevant laws and administrative regulations relating to pharmaceuticals;
The patentable subject matter relating to pharmaceuticals in China;
Administrative protection for patent right;
Civil judicial procedures and remedies for patent right;
Criminal punitions for infringement of patent right;
Design for compositions of optimized protection strategies;
Case studies and comparative analyses of patent infringement disputes.
The English versions of latest Patent Law of the People’s Republic of China and the Rules for the Implementation of the Patent Law of the People's Republic of China to facilitate overseas pharmaceutical manufacturers and multinational pharmaceutical companies to understand the Chinese patent law and regulations
Who should buy this report?
Non- Chinese companies wishing to enter a lucrative drug market in China.
Non- Chinese companies interested in understanding the latest Chinese laws and regulations for pharmaceutical patent protection in China.
Non- Chinese pharmaceutical manufacturers and multinational pharmaceutical companies senior executive officers engaging inpharmaceutical patent protection in China.
Non- Chinese pharmaceutical manufacturers and multinational pharmaceutical companies law affair officers engaging in pharmaceutical patent protection.
Market for China Guidebook for Pharmaceutical Patent Protection
Chapter 1. Introduction 9
Chapter 2 . Organization Structure of Patent Authorities and Judicial
Chapter 3. The Objects of Patent Right 17
Chapter 4. The Patentable Subject Matter Relating to Pharmaceuticals 19
Chapter 5. Application for Patent 23
Chapter 6. Examination and Approval of Application for Patent 34
Chapter 7. Reexamination of Patent Application and Invalidation of Patent Right 51
Chapter 8. Legitimate Rights and Liabilities of Patentee 56
Chapter 9. Limitation of Patent Right 58
Chapter 10. Protection of Patent Right 62
Chapter 11. Compositions of Optimized Protection Strategies 83
Chapter 12. Appendices 114
Similar Market Studies
Vaccines - Global Markets Package http://www.bigmarketresearch.com/vaccines-global-package-market
Vaccines - Eastern European Markets Package http://www.bigmarketresearch.com/vaccines-eastern-european-package-market
Global Anti-Inflammatory Therapeutics Market http://www.bigmarketresearch.com/anti-inflammatory-therapeutics-market
Global Small Molecule Targeted Cancer Therapy Market http://www.bigmarketresearch.com/small-molecule-targeted-cancer-therapy-market
Global DNA Diagnostics Market http://www.bigmarketresearch.com/DNA-diagnostics-market
With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Our research services ranges into different domains and penetrates in different verticals so that we can carter to diverse needs of various organization. Not wrong to quote that this is the hotspot for research needs of yours.Our strength is in our research analysts who with their proactive approach are able to source best and correct information which can be detrimental in organizations success. We follow six sigma standards leaving no scope for error.
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
Toll Free: +1(855)711-1555 (U.S. & Canada)
Email - firstname.lastname@example.org
Web - http://www.bigmarketresearch.com/